• Title of article

    Refractory angina pectoris in end-stage coronary artery disease: Evolving therapeutic concepts, ,

  • Author/Authors

    Frank C. Schoebel، نويسنده , , O.Howard Frazier، نويسنده , , Gilian A.J. Jessurun، نويسنده , , Mike J.L. De Jongste، نويسنده , , Kamuran A. Kadipasaoglu، نويسنده , , Thomas W. Jax، نويسنده , , Matthias P. Heintzen، نويسنده , , Denton A. Cooley، نويسنده , , Bodo E. Strauer، نويسنده , , Matthias Leschke، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 1997
  • Pages
    16
  • From page
    587
  • To page
    602
  • Abstract
    Refractory angina pectoris in coronary artery disease is defined as the persistence of severe anginal symptoms despite maximal conventional antianginal combination therapy. Further, the option to use an invasive revascularization procedure such as percutaneous coronary balloon angioplasty or aortocoronary bypass grafting must be excluded on the basis of a recent coronary angiogram. This coronary syndrome, which represents end-stage coronary artery disease, is characterized by severe coronary insufficiency but only moderately impaired left ventricular function. Almost all patients demonstrated severe coronary triple-vessel disease with diffuse coronary atherosclerosis, had had one or more myocardial infarctions, and had undergone aortocoronary bypass grafting (70% of cases). We present three new approaches with antiischemic properties: long-term intermittent urokinase therapy, transcutaneous and spinal cord electrical nerve stimulation, and transmyocardial laser revascularization. (Am Heart J 1997;134:587-602.)
  • Journal title
    American Heart Journal
  • Serial Year
    1997
  • Journal title
    American Heart Journal
  • Record number

    530997